Abstract

It is known that during pregnancy some viral infections significantly affect fetal development and normal physiological changes in the pregnant woman's body increase susceptibility to respiratory diseases. Thus, pregnant women are more likely to be infected with SARS-CoV-2 and to become ill with COVID-19 than the general population. They are at increased risk of hospitalisation, ventilatory support and other subsequent maternal, fetal and neonatal health problems. Severe COVID-19 infection during pregnancy has been associated with increased adverse perinatal outcomes, although studies differ as to which outcomes it may affect. More detailed characterisation of obstetric and neonatal outcomes is needed, including details of indications for preterm birth and additional neonatal adverse outcomes.

Keywords

References

• Harris RL, Musher DM, Bloom K et al. Manifestations of sepsis. Arch Intern Med 1987; 147: 1895–1906.
• Bossink AW, Groeneveld AB, Hack CE, Thijs LG. Prediction of mortality in febrile medical patients: how useful are systemic inflammatory response syndrome and sepsis criteria? Chest 1998; 113: 1533–1544.
• Bossink AW, Groeneveld AB, Thijs LG. Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999; 29: 398–407.
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379–386.
• Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529–535.
• Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intens Care Med 2005; 31: 213–219.
• Bates DW, Sands K, Miller E et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 1997; 176: 1538–1551.
• Wang SJ, Kuperman GJ, Ohno-Machado L, Onderdonk A, Sandige H, Bates DW. Using electronic data to predict the probability of true bacteremia from positive blood cultures. In: Overhage MJ, ed., Proceedings of the 2000 AMIA
• Symposium. Bethesda, MD: AMIA, 2000; 893–897.
• Aalto H, Takala A, Kautiainen H, Repo H. Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 2004; 23: 699–704.
• Jaimes F, Arango C, Ruiz G et al. Predicting bacteremia at the bedside. Clin Infect Dis 2004; 38: 357–362.

This work is licensed under a Creative Commons Attribution 4.0 International License.